研究成果 (86)

排序依據：日期 | 題名

10 | 25 | 50 | 100

1/9

A B C D E F G H I J K L M N O P R S T V W 全部

Activation and expansion of natural killer cells from liver cancer patients
Siu Tim Cheung, Phyllis F.Y. Cheung Charing C.N. Chong, Stephen L. Chan, Anthony W.H. Chan ( 2016 )
Other conference paper
Adjuvant TS‐1 chemotherapy for Chinese patients with gastric cancer ‐ Assessment of tolerability and associated factors
Winnie Yeo, Ka O Lam, Ada LY Law, Conrad CY Lee, Chi L Chiang, Kwok H Au, Frankie KF Mo, Tsz H So, Wai T Ng, Leung Li, Kwok C Lam ( 2016 )
Invited conference paper presented and published in conference proceedings
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
Park K, Tan EH, O'Byrne K, Zhang L, Boyer M, Mok T, Hirsh V, Yang JCH, Lee KH, Lu S, Shi Y, Kim SW, Laskin J, Kim DW, Arvis CD, Kolbeck AK, Laurie SA, Tsai CM, Shahidi M, Kim M, Massey D, Zazulina V, Paz-Ares L ( 2016 )
LANCET ONCOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/S1470-2045(16)30033-X
ALK FISH Positivity and Crizotinib Efficacy in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
SORIA Jean Charles, HO Steffan N, VARELLA GARCIA Marileila, IAFRATE A A John, SOLOMON Benjamin J, SHAW Alice T, BLACKHALL Fiona Helen, MOK Shu Kam Tony, WU Yi Long, PESTOVA Ekaterina, SIEBERT Fred W, WILNER Keith D, POLLI Anna, PAOLINI Jolanda, LANZALONE Silvana, GREEN Stephanie J, CAMIDGE D Ross ( 2016 )
ASCO 2016 Annual Meeting
Invited conference paper presented and published in conference proceedings
Amide proton transfer (APT) imaging in head and neck cancer: preliminary results'
LAW King Hong Benjamin, KING Ann Dorothy, BHATIA Kunwar Suryaveer Singh, AHUJA Anil Tejbhan, MA Buig Yue Brigette, YEUNG Kw David, WANG Yixiang, YUAN Jing ( 2016 )
24th ISMRM Annual Meeting and Exhibition
Refereed conference paper presented and published in conference proceedings
Anergic natural killer cells in liver cancer patients: ex vivo expansion and activation
Siu Tim Cheung, Phyllis F.Y. Cheung, Charing C.N. Chong, Stephen L. Chan, Anthony W.H. Chan ( 2016 )
Other conference paper
A new prognostic histopathologic classification of nasopharyngeal carcinoma
Wang HY, Chang YL, To KF, Hwang JS, Mai HQ, Feng YF, Chang ET, Wang CP, Kam MK, Cheah SL, Lee M, Gao L, Zhang HZ, He JH, Jiang H, Ma PQ, Zhu XD, Zeng L, Chen CY, Chen G, Huang MY, Fu S, Shao Q, Han AJ, Li HG, Shao CK, Huang PY, Qian CN, Lu TX, Li JT, Ye W, Ernberg I, Ng HK, Wee JT, Zeng YX, Adami HO, Chan AT, Shao JY ( 2016 )
Publication in refereed journal
典藏於此文庫的全文:
40880_2016_Article_103.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1186/s40880-016-0103-5
An update on the pharmacodynamics, pharmacokinetics, safety and clinical efficacy of nivolumab in the treatment of solid cancers
Ashley CY Wong, Brigette Ma ( 2016 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1080/17425255.2016.1223047
Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma
Chan A.W.H., Chong C.C.N., Mo F.K.F., Wong J., Yeo W., Johnson P.J., Yu S., Lai P.B.S., Chan A.T.C., To K.-F., Chan S.L. ( 2016 )
Journal of Gastroenterology and Hepatology (Australia)
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1111/jgh.13339
A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma
MOK Shu Kam Tony, GEATER Sarayut Lucien, SU Wu Chou, TAN Eng Huat, YANG James Chi Hsin, CHANG Gee Chen, HAN May, KOMARNITSKY Philip, PAYUMO Francis, GARRUS Jennifer E, CLOSE Sandra, PARK Keunchil ( 2016 )
Annals of Oncology
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.jtho.2016.05.038

10 | 25 | 50 | 100

1/9

研究成果 (86)

分享連結

Our policy towards the use of cookies